Narrative review / 2023
A German expert panel concluded observational data show no evidence that plasma phytosterol concentrations are linked to higher cardiovascular risk.
An expert panel assessed the potential atherogenicity of phytosterols (PSs) based on metabolism, animal, and human data. Consuming PS-enriched foods increases plasma PSs by ~35%, whereas homozygous phytosterolemia patients exhibit ~4000% higher concentrations where atherosclerosis prevalence is variable and may relate mainly to concomitant elevated LDL-C. Observational studies demonstrate no evidence linking plasma PS concentrations to increased atherosclerosis or cardiovascular events. Because PSs lower LDL-C without adverse safety signals, they offer a dietary approach to cholesterol management, though clinical benefits have not been established in long-term cardiovascular endpoint studies.
- Study type
- Expert panel statement / narrative review
- Who was studied
- Homozygous phytosterolemia patients, general populations, and consumers of phytosterol-enriched foods
- What was measured
- Atherogenicity, plasma phytosterol and LDL-C concentrations, atherosclerosis, cardiovascular risk
THE PAPER
Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases-A German Expert Panel Statement.
Windler E, Beil FU, Berthold HK, Gouni-Berthold I, Kassner U, Klose G, Lorkowski S, März W, Parhofer KG, Plat J, Silbernagel G, Steinhagen-Thiessen E, Weingärtner O, Zyriax BC, Lütjohann D. Nutrients, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.